Future aspects of regulation.
Slater
Jay E
JE
US Food and Drug Administration, Center for Biologics Evaluation, 1401 Rockville Pike (HFM-422), Rockville, MD 20852, USA.
D000485:Allergens / Q000627:therapeutic use*; D004335:Drug and Narcotic Control / Q000639:trends*; D006801:Humans; D006967:Hypersensitivity / Q000628:therapy*; D008004:Licensure; D011994:Recombinant Proteins / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration / Q000639:trends*
D000485:Allergens; D011994:Recombinant Proteins